- Home
- SBFG vs CSBR Comparison
SBFG vs CSBR Comparison
Compare SBFG & CSBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBFG
- CSBR
- Stock Information
- Founded
- SBFG 1983
- CSBR 1985
- Country
- SBFG United States
- CSBR United States
- Employees
- SBFG N/A
- CSBR N/A
- Industry
- SBFG Major Banks
- CSBR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SBFG Finance
- CSBR Health Care
- Exchange
- SBFG Nasdaq
- CSBR Nasdaq
- Market Cap
- SBFG 132.3M
- CSBR 123.2M
- IPO Year
- SBFG N/A
- CSBR 1986
- Fundamental
- Price
- SBFG $20.38
- CSBR $8.30
- Analyst Decision
- SBFG
- CSBR Strong Buy
- Analyst Count
- SBFG 0
- CSBR 1
- Target Price
- SBFG N/A
- CSBR $12.00
- AVG Volume (30 Days)
- SBFG 24.4K
- CSBR 30.4K
- Earning Date
- SBFG 10-23-2025
- CSBR 09-15-2025
- Dividend Yield
- SBFG 2.87%
- CSBR N/A
- EPS Growth
- SBFG 2.59
- CSBR N/A
- EPS
- SBFG 1.83
- CSBR 0.33
- Revenue
- SBFG $61,225,000.00
- CSBR $56,944,000.00
- Revenue This Year
- SBFG N/A
- CSBR $9.30
- Revenue Next Year
- SBFG N/A
- CSBR $31.17
- P/E Ratio
- SBFG $11.42
- CSBR $24.12
- Revenue Growth
- SBFG 9.45
- CSBR 13.54
- 52 Week Low
- SBFG $16.56
- CSBR $3.75
- 52 Week High
- SBFG $24.48
- CSBR $11.99
- Technical
- Relative Strength Index (RSI)
- SBFG 40.83
- CSBR 68.02
- Support Level
- SBFG $20.00
- CSBR $6.33
- Resistance Level
- SBFG $21.74
- CSBR $7.25
- Average True Range (ATR)
- SBFG 0.65
- CSBR 0.40
- MACD
- SBFG -0.16
- CSBR 0.09
- Stochastic Oscillator
- SBFG 16.10
- CSBR 81.74
About SBFG SB Financial Group Inc.
SB Financial Group Inc that provides a range of community banking services, including commercial and consumer lending, personal and business banking, treasury management and merchant services, personal wealth management and brokerage services, and other financial services to individuals, businesses, and municipalities. It operates in single segment which is Banking.
About CSBR Champions Oncology Inc.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.